EQ Equillium Inc
Price (delayed)
$0.491
Market cap
$17.48M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.23
Enterprise value
-$216,536
Equillium is a clinical-stage biotechnology company leveraging deep understanding of immunobiology to develop novel products to treat severe autoimmune and inflammatory disorders with high unmet medical need. Equillium is developing
Highlights
The quick ratio has soared by 119% YoY and by 27% from the previous quarter
Equillium's debt has shrunk by 53% YoY and by 23% QoQ
The EPS has dropped by 77% since the previous quarter but it has increased by 39% year-on-year
EQ's net income has dropped by 75% since the previous quarter but it is up by 40% year-on-year
The equity has contracted by 18% from the previous quarter and by 16% YoY
Key stats
What are the main financial stats of EQ
Market
Valuations
Earnings
Shares outstanding
35.61M
Market cap
$17.48M
Enterprise value
-$216,536
Price to earnings (P/E)
N/A
Price to book (P/B)
0.91
Price to sales (P/S)
0.42
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
-0.01
Revenue
$41.1M
Gross profit
$41.1M
Operating income
-$8.27M
Net income
-$8.07M
EBIT
-$7.71M
EBITDA
-$7.57M
Free cash flow
-$19.11M
Per share
Balance sheet
Liquidity
EPS
-$0.23
EPS diluted
-$0.23
Free cash flow per share
-$0.54
Book value per share
$0.54
Revenue per share
$1.16
TBVPS
$0.72
Total assets
$25.6M
Total liabilities
$6.54M
Debt
$384,000
Equity
$19.06M
Working capital
$18.62M
Debt to equity
0.02
Current ratio
3.93
Quick ratio
3.55
Net debt/EBITDA
2.34
Margins
Efficiency
Dividend
EBITDA margin
-18.4%
Gross margin
100%
Net margin
-19.6%
Operating margin
-20.1%
Return on assets
-22%
Return on equity
-37.6%
Return on invested capital
-94%
Return on capital employed
-40%
Return on sales
-18.8%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
EQ stock price
How has the Equillium stock price performed over time
Intraday
-2.54%
1 week
-35.22%
1 month
-35.72%
1 year
-77.48%
YTD
-34.38%
QTD
25.16%
Financial performance
How have Equillium's revenue and profit performed over time
Revenue
$41.1M
Gross profit
$41.1M
Operating income
-$8.27M
Net income
-$8.07M
Gross margin
100%
Net margin
-19.6%
Equillium's net margin has shrunk by 94% QoQ but it has increased by 47% YoY
EQ's net income has dropped by 75% since the previous quarter but it is up by 40% year-on-year
EQ's operating margin has soared by 50% YoY but it is down by 37% from the previous quarter
The operating income is up by 43% year-on-year but it has declined by 22% since the previous quarter
Growth
What is Equillium's growth rate over time
Valuation
What is Equillium stock price valuation
P/E
N/A
P/B
0.91
P/S
0.42
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
-0.01
The EPS has dropped by 77% since the previous quarter but it has increased by 39% year-on-year
The price to book (P/B) is 51% lower than the last 4 quarters average of 1.9 and 45% lower than the 5-year quarterly average of 1.7
The equity has contracted by 18% from the previous quarter and by 16% YoY
The stock's P/S is 57% less than its last 4 quarters average of 1.0
Equillium's revenue has increased by 14% YoY but it has decreased by 10% from the previous quarter
Efficiency
How efficient is Equillium business performance
The company's return on assets has shrunk by 104% QoQ but it rose by 2.7% YoY
The return on sales has dropped by 88% since the previous quarter but it has increased by 45% year-on-year
The ROE has plunged by 82% from the previous quarter but it has grown by 27% YoY
The ROIC has dropped by 62% since the previous quarter but it is up by 48% year-on-year
Dividends
What is EQ's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for EQ.
Financial health
How did Equillium financials performed over time
The company's current ratio has surged by 120% YoY and by 29% QoQ
The quick ratio has soared by 119% YoY and by 27% from the previous quarter
Equillium's debt is 98% lower than its equity
Equillium's debt has shrunk by 53% YoY and by 23% QoQ
EQ's debt to equity has dropped by 50% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.